Gabelli Funds’s Accendra Health ACH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-188,000
| Closed | -$902K | – | 1278 |
|
|
2025
Q3 | $902K | Sell |
188,000
-98,000
| -34% | -$623K | 0.01% | 935 |
|
|
2025
Q2 | $2.6M | Sell |
286,000
-40,000
| -12% | -$295K | 0.02% | 671 |
|
|
2025
Q1 | $2.94M | Hold |
326,000
| – | – | 0.02% | 571 |
|
|
2024
Q4 | $4.26M | Buy |
326,000
+146,000
| +81% | +$1.95M | 0.03% | 487 |
|
|
2024
Q3 | $2.82M | Buy |
180,000
+5,000
| +3% | +$75.7K | 0.02% | 587 |
|
|
2024
Q2 | $2.36M | Buy |
175,000
+5,000
| +3% | +$102K | 0.02% | 620 |
|
|
2024
Q1 | $4.71M | Buy |
170,000
+35,000
| +26% | +$777K | 0.03% | 471 |
|
|
2023
Q4 | $2.6M | Buy |
135,000
+17,500
| +15% | +$317K | 0.02% | 610 |
|
|
2023
Q3 | $1.9M | Buy |
+117,500
| New | +$2.09M | 0.02% | 664 |
|
|
2021
Q2 | – | Sell |
-16,900
| Closed | -$635K | – | 1369 |
|
|
2021
Q1 | $635K | Buy |
+16,900
| New | +$528K | ﹤0.01% | 983 |
|
|
2020
Q4 | – | Sell |
-22,500
| Closed | -$565K | – | 1227 |
|
|
2020
Q3 | $565K | Sell |
22,500
-163,000
| -88% | -$2.38M | ﹤0.01% | 915 |
|
|
2020
Q2 | $1.41M | Buy |
185,500
+4,300
| +2% | +$31.5K | 0.01% | 736 |
|
|
2020
Q1 | $1.66M | Hold |
181,200
| – | – | 0.01% | 678 |
|
|
2019
Q4 | $937K | Sell |
181,200
-5,700
| -3% | -$36.6K | 0.01% | 871 |
|
|
2019
Q3 | $1.09M | Sell |
186,900
-2,900
| -2% | -$13K | 0.01% | 846 |
|
|
2019
Q2 | $607K | Buy |
189,800
+24,500
| +15% | +$83.6K | ﹤0.01% | 963 |
|
|
2019
Q1 | $678K | Buy |
165,300
+12,400
| +8% | +$78.4K | ﹤0.01% | 937 |
|
|
2018
Q4 | $968K | Sell |
152,900
-13,200
| -8% | -$137K | 0.01% | 859 |
|
|
2018
Q3 | $2.74M | Sell |
166,100
-54,892
| -25% | -$933K | 0.02% | 723 |
|
|
2018
Q2 | $3.69M | Sell |
220,992
-1,000
| -0.5% | -$16.2K | 0.02% | 640 |
|
|
2018
Q1 | $3.45M | Buy |
221,992
+1,000
| +0.5% | +$17.8K | 0.02% | 643 |
|
|
2017
Q4 | $4.17M | Buy |
220,992
+2,492
| +1% | +$55.3K | 0.02% | 611 |
|
|
2017
Q3 | $6.38M | Hold |
218,500
| – | – | 0.04% | 517 |
|
|
2017
Q2 | $7.03M | Buy |
218,500
+2,322
| +1% | +$76.2K | 0.04% | 476 |
|
|
2017
Q1 | $7.48M | Hold |
216,178
| – | – | 0.04% | 460 |
|
|
2016
Q4 | $7.63M | Hold |
216,178
| – | – | 0.05% | 448 |
|
|
2016
Q3 | $7.51M | Hold |
216,178
| – | – | 0.04% | 446 |
|
|
2016
Q2 | $8.08M | Hold |
216,178
| – | – | 0.05% | 437 |
|
|
2016
Q1 | $8.74M | Hold |
216,178
| – | – | 0.05% | 414 |
|
|
2015
Q4 | $7.78M | Hold |
216,178
| – | – | 0.05% | 440 |
|
|
2015
Q3 | $6.91M | Hold |
216,178
| – | – | 0.04% | 479 |
|
|
2015
Q2 | $7.35M | Hold |
216,178
| – | – | 0.04% | 488 |
|
|
2015
Q1 | $7.32M | Hold |
216,178
| – | – | 0.04% | 505 |
|
|
2014
Q4 | $7.59M | Buy |
216,178
+2,000
| +0.9% | +$67.4K | 0.04% | 498 |
|
|
2014
Q3 | $7.01M | Hold |
214,178
| – | – | 0.04% | 506 |
|
|
2014
Q2 | $7.28M | Buy |
214,178
+14,678
| +7% | +$503K | 0.04% | 516 |
|
|
2014
Q1 | $6.99M | Buy |
199,500
+4,000
| +2% | +$141K | 0.04% | 504 |
|
|
2013
Q4 | $7.15M | Hold |
195,500
| – | – | 0.04% | 479 |
|
|
2013
Q3 | $6.76M | Buy |
195,500
+10,000
| +5% | +$350K | 0.04% | 483 |
|
|
2013
Q2 | $6.28M | Buy |
+185,500
| New | +$6.16M | 0.04% | 476 |
|
Other funds holding ACH
CCM
ICM
PCMI
Gabelli Funds's ACH Position: Q4 2025 in Review
Gabelli Funds sold out of Accendra Health (ACH) in Q4 2025, closing a stake of 188,000 shares — an estimated $902K sold.
Gabelli Funds first reported a position in ACH in Q2 2013 and held it in 40 quarters. The position peaked at $8.74M in Q1 2016. 168 funds tracked by Wall St. Rank hold ACH as of Q4 2025.
- Gabelli Funds reported no remaining Accendra Health position as of Q4 2025 after selling out during the quarter.
- Gabelli Funds sold 188,000 Accendra Health shares in Q4 2025, an estimated $902K.
- Gabelli Funds first reported a position in Accendra Health in Q2 2013 and held it in 40 quarters.
- Gabelli Funds's Accendra Health position peaked at $8.74M in Q1 2016.
- 168 funds tracked by Wall St. Rank held Accendra Health as of Q4 2025.
Based on Gabelli Funds's 13F filing for Q4 2025, filed 5 Feb 2026.